Which company did well over launching new drugs in first half?

When it comes to new drug launches made by multinational pharmaceutical companies in the first half of the year, Boehringer Ingelheim Korea and Lilly Korea were known to lead, and the most common one was anticancer drugs.

According to the analysis result of multinational companies’ products launched in Korea between January and June this year, the total 16 products have appeared in the market....